Nebenwirkungen · Gardasil
Gardasil suspension for injection. Gardasil suspension for injection in a pre-filled syringe. Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed). · Abschnitt 4.8 · PDF-Seite 5–6
HOS-116240 · Präparat HOS-094431
5 predefined subset (one study) of the study population using vaccination report card (VRC)-aided surveillance for 14 days after each injection of Gardasil or placebo. The individuals who were monitored using VRC-aided surveillance included 10,088 individuals (6,995 females 9 to 45 years of age and 3,093 males 9 to 26 years of age at enrolment) who received Gardasil and 7,995 individuals (5,692 females and 2,303 males) who received placebo.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-20T11:35:00Z · SHA-256 e89fa50e1a391a8c065f4028bfd1c63d5aeb15de9278e038e79343ad89ef236e · Passage ca8b00c9bbbf7929f33df0821e8afcda3c2fc7208e26f27787a0eac5021a19f6 · Zeichen 391–836 im Abschnitt